Vital Signs: Hepatitis C Treatment Among Insured Adults - United States, 2019-2020.
Introduction: Over 2 million adults in the United States have hepatitis C virus (HCV) infection, and it contributes to approximately 14,000 deaths a year. Eight to 12 weeks of highly effective direct-acting antiviral (DAA) treatment, which can cure ≥95% of cases, is recommended for persons with hepa...
| Publicado en: | MMWR: Morbidity & Mortality Weekly Report Vol. 71; no. 32; pp. 1011 - 1018 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Centers for Disease Control & Prevention (CDC)
8/12/2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |